REVIEW ARTICLE

Year : 2010  |  Volume : 6  |  Issue : 4  |  Page : 427-431

From tumor immunology to cancer immunotherapy: Miles to go

Manjul Tiwari
Departments of Oral Pathology and Microbiology, School of Dental Sciences, Sharda University, Greater Noida Uttar Pradesh, India

Correspondence Address:
Manjul Tiwari
D-97, Anupam Apartments, B/13, Vasundhara Enclave, Delhi - 110096
India

Source of Support: None, Conflict of Interest: None

Check

4

DOI: 10.4103/0973-1482.77071

Advances in tumor immunology are supporting the clinical implementation of several immunological approaches to cancer in the clinical setting. However, the alternate success of current immunotherapeutic regimens underscores the fact that the molecular mechanisms underlying immune-mediated tumor rejection are still poorly understood. Given the complexity of the immune system network and the multidimensionality of tumor/host interactions, the comprehension of tumor immunology might greatly benefit from high-throughput microarray analysis, which can portrait the molecular kinetics of immune response on a genome-wide scale, thus accelerating the discovery pace and ultimately catalyzing the development of new hypotheses in cell biology. Although the general principles of microarray-based gene profiling with the application of DNA microarray have rapidly spread in the scientific community, the need for mastering this technique to produce meaningful data and correctly interpret the enormous output of information generated by this technology is critical and represents a tremendous challenge for investigators. To describe the sequence of events conductive to an effective immune recognition and killing of malignant cells, clinicians might use gene profiling as a powerful tool to assess the activation status of the immune system before and during immunotherapy.

Keywords: DNA microarray, immune-mediated tumors, microarray, tumor immunology

The following article is been Retracted

This article has been cited by 1 BAP31, a promising target for the immunotherapy of malignant melanomas Shaojuan Yu, Fuli Wang, Li Fan, Yuying Wei, Haitao Li, Yuanjie Sun, Angang Yang, Boquan Jin, Chaojun Song, Kun Yang Journal of Experimental & Clinical Cancer Research. 2015; 34(1) [Pubmed] | [DOI] 2 Elevated level of peripheral CD8+CD28- T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy Song, G. and Wang, X. and Jia, J. and Yuan, Y. and Wan, F. and Zhou, X. and Yang, H. and Ren, J. and Gu, J. and Lyerly, H.K. Cancer Immunology, Immunotherapy. 2013; 62(6): 1123-1130 [Pubmed] 3 Indoleamine 2,3-dioxygenase inhibitory activity of derivatives of marine alkaloid tsitsikammamine A DoluÅ¡ić, E. and Larrieu, P. and Meinguet, C. and Colette, D. and Rives, A. and Blanc, S. and Ferain, T. and Pilotte, L. and Stroobant, V. and Wouters, J. and Van Den Eynde, B. and Masereel, B. and Delfourne, E. and Frédérick, R. Bioorganic and Medicinal Chemistry Letters. 2013; 23(1): 47-54 [Pubmed] 4 Elevated level of peripheral CD8+CD28- T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy Guohong Song,Xiaoli Wang,Jun Jia,Yanhua Yuan,Fengling Wan,Xinna Zhou,Huabing Yang,Jun Ren,Jiezhun Gu,Herbert Kim Lyerly Cancer Immunology, Immunotherapy. 2013; 62(6): 1123 [Pubmed] | [DOI] 5 Characteristics of New Monomolecular Chimeric T-Cell Receptors to Carcinoembryonic Antigen V. K. Bozhenko,E. I. Shramova,A. M. Shishkin,A. V. Ivanov,E. V. Khokhlova,Yu. S. Lebedin,A. N. Shkoporov Bulletin of Experimental Biology and Medicine. 2013; [Pubmed] | [DOI] 6 Indoleamine 2,3-dioxygenase inhibitory activity of derivatives of marine alkaloid tsitsikammamine A Eduard Dolušic,Pierre Larrieu,Céline Meinguet,Delphine Colette,Arnaud Rives,Sébastien Blanc,Thierry Ferain,Luc Pilotte,Vincent Stroobant,Johan Wouters,Benoît Van den Eynde,Bernard Masereel,Evelyne Delfourne,Raphaël Frédérick Bioorganic & Medicinal Chemistry Letters. 2013; 23(1): 47 [Pubmed] | [DOI] 7 Macrophage–tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands Thomas Schmidt,Isabel Ben-Batalla,Alexander Schultze,Sonja Loges Cellular and Molecular Life Sciences. 2012; 69(9): 1391 [Pubmed] | [DOI] 8 Macrophage-tumor crosstalk: Role of TAMR tyrosine kinase receptors and of their ligands Schmidt, T., Ben-Batalla, I., Schultze, A., Loges, S. Cellular and Molecular Life Sciences. 2012; 69(9): 1391-1414 [Pubmed]